Jupiter Life Line Hospitals Limited

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.
Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the "Jupiter" brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.
According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
The company's inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.


Objects of the Issue
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

  • Repayment/pre-payment, in full or part, of borrowings availed from banks by the company and Material Subsidiary; and
  • General corporate purposes.



ISSUE OPENS
September 6, 2023

Issue Closes
September 8, 2023

Issue Price
₹695 to ₹735 per share

BID LOT
Minimum of 20 Equity shares & in multiple of 20 Equity shares thereafter.

ALLOTMENT DATE
September 13, 2023

IPO Ratio
QIB 50% - Retail 35% - NII 15%

IPO Size
₹869.08 Cr

Company Financials

Period Ended 31-Mar-21 31-Mar-22 31-Mar-23
Assets 788.91 908.7 985.53
Revenue 490.27 737.14 902.96
Profit After Tax -2.3 51.13 72.91
Net Worth 246.44 288.43 363.91
Reserves and Surplus    
Total Borrowing 425.52 495.25 468.63

Apply Now

You can Invest via:

  201404210316526522603845   201404210316526522603171   201404210316526522603762   201606080432378699589304.jpg

Open Account Now